684 healthcare executives, clinicians and technology leaders rank vendors across 19 categories as buyers elevate interoperability, clinical continuity and implementation...
Infinitum founder and Groq board director brings frontier AI and technology-investing expertise to Biohaven as the company advances AI-enabled approaches to...
First pivotal cohort enrolled 300 subjects, with topline clinical data from 24-week primary endpoint on track for December 2026 releaseCompletion...
Acquisition includes clinical-stage neuroplastogenic therapy with U.S. FDA Orphan Drug Designation for the treatment of Complex Regional Pain Syndrome (CRPS)Up...
mFLUSIVA becomes Moderna's fifth approved product globally and fourth FDA-approved productCompany expects supply to be available in select retailers in...
Zomedica surpasses $9 million in second quarter revenue for the first time while extending its record of consecutive year-over-year revenue...
ICOTYDE™ First Full Quarter of Commercial Sales with Strong Early AdoptionRusfertide NDA under Priority Review for Polycythemia Vera; PDUFA Date...
NYSE issues a pre-market daily advisory direct from the trading floor.NEW YORK, Aug. 5, 2026 /PRNewswire/ -- The New York...
Custom Health has entered into a definitive agreement to acquire Spencer Health Solutions, which is expected to unite Custom Health's...
CALGARY, Alberta, Aug. 05, 2026 (GLOBE NEWSWIRE) -- Marvel Biosciences Corp. (TSXV: MRVL | OTC: MBCOF), and its wholly-owned subsidiary,...
Toronto, Ontario--(Newsfile Corp. - August 4, 2026) - Rhelion Life Sciences Corp. (CSE: RHEL) (OTCQB: TRUFF) (FSE: 4YX) ("Rhelion" or...
ANDOVER, Mass., Aug. 4, 2026 /PRNewswire/ -- TransMedics Group, Inc. ("TransMedics") (Nasdaq: TMDX), a medical technology company that is transforming organ...
New BioSymetrics Inc. white paper and executed Master Collaboration Agreement establish an integrated roadmap spanning AI-driven patient stratification, human translational...
NEW YORK, Aug. 4, 2026 /PRNewswire/ -- AEYE Health, the leader in ophthalmic AI and retinal diagnostics and the developer...
Upcoming free, educational webinars from Xtalks will feature topics on clinical trials, patient recruitment and retention, drug safety, laboratory technologies,...
Phase 1 trial will evaluate safety and immune response for a strain of Ebola virus disease with no licensed vaccines...
The Platform integrates clinically researched stem and progenitor cell mobilization with ingredients that have been studied for their roles in...
The accessory reduces sound in the treatment environment while maintaining the trusted efficacy of PulseVet® shock wave therapy ANN ARBOR,...
PHILADELPHIA, Aug. 3, 2026 /PRNewswire/ -- Signant Health, the evidence generation company, today announced the launch of Forecasting & Planning Assist™,...
The qualification puts co-pay assistance, drug education, and clinical trial eligibility inside the prescribing moment, and makes Spark available to...